Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 467841 - 467860 out of 476556 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (A16AB19) pegvaliase | PALYNZIQ 20MG/ML INJ,SYR,1ML | 10X1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Phenylketonurias | BioMarinPharmaceutical,Inc. |
| USA | (A16AB20) pegunigalsidase alfa | ELFABRIO 2MG/ML SOLN INJ | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | ChiesiUSA,Inc. |
| USA | (A16AB20) pegunigalsidase alfa | ELFABRIO 2MG/ML SOLN INJ | 10X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | ChiesiUSA,Inc. |
| USA | (A16AB20) pegunigalsidase alfa | ELFABRIO 2MG/ML SOLN INJ | 5X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | ChiesiUSA,Inc. |
| USA | (A16AB23) cipaglucosidase alfa | POMBILITI 105MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Glycogen Storage Disease Type II | AmicusTherapeuticsUS,LLC |
| USA | (A16AB23) cipaglucosidase alfa | POMBILITI 105MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Glycogen Storage Disease Type II | AmicusTherapeuticsUS,LLC |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 20MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 20MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 4MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 4MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AX) various alimentary tract and metabolism products | RIVFLOZA 160MG/ML INJ,SOLN SYRINGE | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovoNordiskInc. |
| USA | (A16AX) various alimentary tract and metabolism products | RIVFLOZA 160MG/ML INJ,SOLN SYRINGE | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovoNordiskInc. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 250GM | 250GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 250GM | 250GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 500MG TAB | 250 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 500MG TAB | 250 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | OLPRUVA 2GM/PKT PWDR,ORAL | 2GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AcerTherapeutics,Inc. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | OLPRUVA 3GM/PKT PWDR,ORAL | 3GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AcerTherapeutics,Inc. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | OLPRUVA 4GM/PKT PWDR,ORAL | 4GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AcerTherapeutics,Inc. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | OLPRUVA 5GM/PKT PWDR,ORAL | 5GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AcerTherapeutics,Inc. |
Pages
